FDA Clearance Tracker · P210025
SurVeil Drug-Coated Balloon
Last checked: Nov 20, 2026Latest source record: Jun 16, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Jun 16, 2023
Approved
Time to decision
725 days
Received Jun 21, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P210025
- Device name
- SurVeil Drug-Coated Balloon
- Applicant
- Surmodics,Inc.
- Applicant location
- Eden Prairie, MN
- Received
- Jun 21, 2021
- Decided
- Jun 16, 2023
- Decision
- Approved
- Supplements
- 6 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the SurVeil DCB. The device is indicated for use for percutaneous transluminal angioplasty, after appropriate vessel preparation, of de novo or restenotic lesions (</= 180 mm in length) in femoral and popliteal arteries having reference vessel diameters of 4 mm to 7 mm.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code ONU. The earliest in FDA's data is P130024, decided Oct 9, 2014.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Surmodics,Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Pounce(TM) Sheath510(k)
K252227 · Decided Sep 24, 2025 · 70 days after receipt
Device type: Introducer, Catheter (DYB) · Cardiology
K242419 · Decided Nov 15, 2024 · 92 days after receipt
Device type: Catheter, Angioplasty, Peripheral, Transluminal (LIT) · Cardiology
K241362 · Decided Sep 11, 2024 · 120 days after receipt
Device type: Peripheral Mechanical Thrombectomy With Aspiration (QEW) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.